These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 12450690)

  • 1. Candidate peptide vaccine induced protection against classical swine fever virus.
    Dong XN; Wei K; Liu ZQ; Chen YH
    Vaccine; 2002 Dec; 21(3-4):167-73. PubMed ID: 12450690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate peptide-vaccine induced potent protection against CSFV and identified a principal sequential neutralizing determinant on E2.
    Dong XN; Qi Y; Ying J; Chen X; Chen YH
    Vaccine; 2006 Jan; 24(4):426-34. PubMed ID: 16154668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs.
    de Smit AJ; Bouma A; van Gennip HG; de Kluijver EP; Moormann RJ
    Vaccine; 2001 Jan; 19(11-12):1467-76. PubMed ID: 11163670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein E2 of classical swine fever virus expressed by baculovirus induces the protective immune responses in rabbits.
    Zhang H; Li X; Peng G; Tang C; Zhu S; Qian S; Xu J; Qian P
    Vaccine; 2014 Nov; 32(49):6607-13. PubMed ID: 25446823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination.
    de Smit AJ; Bouma A; de Kluijver EP; Terpstra C; Moormann RJ
    Vet Microbiol; 2001 Feb; 78(4):307-17. PubMed ID: 11182497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.
    Barrera M; Sánchez O; Farnós O; Rodríguez MP; Domínguez P; Tait H; Frías M; Avila M; Vega E; Toledo JR
    Vet Immunol Immunopathol; 2010 Jan; 133(1):25-32. PubMed ID: 19640591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Unique Glycosylation at Position 986 on the E2 Glycoprotein of Classical Swine Fever Virus Is Responsible for Viral Attenuation and Protection against Lethal Challenge.
    Li Y; Yuan M; Han Y; Xie L; Ma Y; Li S; Sun Y; Luo Y; Li W; Qiu HJ
    J Virol; 2022 Jan; 96(2):e0176821. PubMed ID: 34730400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and Efficacy Evaluation of a Recombinant Pseudorabies Virus Variant Expressing the E2 Protein of Classical Swine Fever Virus in Pigs.
    Wang Y; Yuan J; Cong X; Qin HY; Wang CH; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
    Clin Vaccine Immunol; 2015 Oct; 22(10):1121-9. PubMed ID: 26311244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate peptide-vaccines induced immunity against CSFV and identified sequential neutralizing determinants in antigenic domain A of glycoprotein E2.
    Dong XN; Chen YH
    Vaccine; 2006 Mar; 24(11):1906-13. PubMed ID: 16300867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs.
    Uttenthal A; Le Potier MF; Romero L; De Mia GM; Floegel-Niesmann G
    Vet Microbiol; 2001 Nov; 83(2):85-106. PubMed ID: 11557151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).
    Voigt H; Merant C; Wienhold D; Braun A; Hutet E; Le Potier MF; Saalmüller A; Pfaff E; Büttner M
    Vaccine; 2007 Aug; 25(31):5915-26. PubMed ID: 17600594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus.
    Reimann I; Depner K; Trapp S; Beer M
    Virology; 2004 Apr; 322(1):143-57. PubMed ID: 15063124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
    Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
    Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bivalent dendrimeric peptide bearing a T-cell epitope from foot-and-mouth disease virus protein 3A improves humoral response against classical swine fever virus.
    Bohórquez JA; Defaus S; Muñoz-González S; Perez-Simó M; Rosell R; Fraile L; Sobrino F; Andreu D; Ganges L
    Virus Res; 2017 Jun; 238():8-12. PubMed ID: 28571760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant pseudorabies virus expressing E2 of classical swine fever virus (CSFV) protects against both virulent pseudorabies virus and CSFV.
    Tong W; Zheng H; Li GX; Gao F; Shan TL; Zhou YJ; Yu H; Jiang YF; Yu LX; Li LW; Kong N; Tong GZ; Li JC
    Antiviral Res; 2020 Jan; 173():104652. PubMed ID: 31751590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple linear B-cell epitopes of classical swine fever virus glycoprotein E2 expressed in E.coli as multiple epitope vaccine induces a protective immune response.
    Zhou B; Liu K; Jiang Y; Wei JC; Chen PY
    Virol J; 2011 Jul; 8():378. PubMed ID: 21801433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response.
    van Gennip HG; van Rijn PA; Widjojoatmodjo MN; de Smit AJ; Moormann RJ
    Vaccine; 2000 Oct; 19(4-5):447-59. PubMed ID: 11027808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P108 and T109 on E2 Glycoprotein Domain I Are Critical for the Adaptation of Classical Swine Fever Virus to Rabbits but Not for Virulence in Pigs.
    Xie L; Han Y; Ma Y; Yuan M; Li W; Li LF; Li M; Sun Y; Luo Y; Li S; Hu S; Li Y; Qiu HJ
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy evaluation of the C-strain-based vaccines against the subgenotype 2.1d classical swine fever virus emerging in China.
    Luo Y; Ji S; Lei JL; Xiang GT; Liu Y; Gao Y; Meng XY; Zheng G; Zhang EY; Wang Y; Du ML; Li Y; Li S; He XJ; Sun Y; Qiu HJ
    Vet Microbiol; 2017 Mar; 201():154-161. PubMed ID: 28284603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A promising multiple-epitope recombinant vaccine against classical swine fever virus.
    Tian H; Hou X; Wu J; Chen Y; Shang Y; Yin S; Zhang K; Liu X
    Vet Immunol Immunopathol; 2014 Jan; 157(1-2):59-64. PubMed ID: 24269058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.